Phenyltoloxamine: Difference between revisions
Brian Blank (talk | contribs) No edit summary |
m (Protected "Phenyltoloxamine": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
(No difference)
|
Latest revision as of 18:57, 27 September 2011
Clinical data | |
---|---|
Routes of administration | oral |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C17H21NO |
Molar mass | 255.359 |
WikiDoc Resources for Phenyltoloxamine |
Articles |
---|
Most recent articles on Phenyltoloxamine Most cited articles on Phenyltoloxamine |
Media |
Powerpoint slides on Phenyltoloxamine |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Phenyltoloxamine at Clinical Trials.gov Trial results on Phenyltoloxamine Clinical Trials on Phenyltoloxamine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Phenyltoloxamine NICE Guidance on Phenyltoloxamine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Phenyltoloxamine Discussion groups on Phenyltoloxamine Patient Handouts on Phenyltoloxamine Directions to Hospitals Treating Phenyltoloxamine Risk calculators and risk factors for Phenyltoloxamine
|
Healthcare Provider Resources |
Causes & Risk Factors for Phenyltoloxamine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Phenyltoloxamine is an antihistamine with sedative and analgesic effects. It is a member of the ethanolamine class of antihistaminergic agents and a potent anticholinergic.
Common use
Phenyltoloxamine is widely used in preparations as an enhancing agent for some analgesics and antitussives (acetaminophen, codeine, hydrocodone). It is widely used in certain parts of the world as cough suppressant usually with codeine.
It also used to discourage abuse in certain opiate analgesics due its unpleasant side effects at high doses.
Adverse effects
Common adverse effects are those associated with most anticholinergics, effects are more pronounced in children and the elderly.
Availability
Phenyltoloxamine is available in most countries, though is rare in several western countries it remains widely used around the world, particularly in the developing world.
It is not a controlled substance; however some preparations contain opiates such as codeine or hydrocodone and are controlled, when used in preparations with acetaminophen is generally over the counter.
Phenyltoloxamine is sold under wide variety of preparations, brand names and dosages around the world:
- Ed-Flex, Dologesic, Flextra-650, Novagesic, Phenylgesic - North America
- Codipront - Europe/South America
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Articles containing unverified chemical infoboxes
- Antihistamines